Non-viral engineering of skin precursor-derived Schwann cells for enhanced NT-3 production in adherent and microcarrier culture

Current Medicinal Chemistry

Volumn 19, Issue 32, 2012, Pages 5572-5579

  Shakhbazau, A ^a,b   Shcharbin, D ^c   Bryszewska, M ^d   Kumar, R ^a,b   Wobma, H M ^a   Kallos, M S ^a   Goncharova, N ^e   Seviaryn, I ^e   Kosmacheva, S ^e   Potapnev, M ^e   Midha, R ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c INSTITUTE OF PHOTOBIOLOGY   (Belarus)

^d UNIVERSITY OF LODZ   (Poland)

^e Republic Centre for Hematology and Transfusiology   (Belarus)

Author keywords

Cytodex 3; Dendrimers; Lipofectamine; Microcarriers; Non viral gene delivery; NT 3; PAMAM; Peripheral nerve; Skin precursor derived Schwann cells; Transfection

Indexed keywords

DENDRIMER; NEUROTROPHIN 3; POLYAMIDOAMINE;

ADHERENT CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOREACTOR; CELL FREE SYSTEM; CELL STRAIN HEK293; CONCEPT ANALYSIS; CONTROLLED STUDY; EMBRYO; FEASIBILITY STUDY; FEMALE; GENETIC ENGINEERING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MICROCARRIER CULTURE; NERVE FIBER REGENERATION; NERVE INJURY; NERVOUS TISSUE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; SCHWANN CELL; SKIN; STEM CELL;

ANIMALS; CELLS, CULTURED; DENDRIMERS; FEMALE; HEK293 CELLS; HUMANS; NERVE REGENERATION; NEUROTROPHIN 3; POLYPROPYLENES; RATS; RATS, INBRED LEW; SCHWANN CELLS; SCIATIC NERVE; SKIN; STEM CELL TRANSPLANTATION; TRANSFECTION;

EID: 84870406750     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712803833218     Document Type: Article

References (74)

1. Biernaskie, J., Sparling, J.S., Liu, J., Shannon, C.P., Plemel, J.R., Xie, Y., Miller, F.D., Tetzlaff, W. Skin-derived precursors generate myelinating Schwann cells that promote remyelination and functional recovery after contusion spinal cord injury. J. Neurosci., 2007, 27(36), 9545-9559
2. McKenzie, I.A., Biernaskie, J., Toma, J.G., Midha, R., Miller, F.D. Skin-derived precursors generate myelinating Schwann cells for the injured and dysmyelinated nervous system. J. Neurosci., 2006, 26(24), 6651-6660
3. Toma, J.G., McKenzie, I.A., Bagli, D., Miller, F.D. Isolation and characterization of multipotent skin-derived precursors from human skin. Stem Cells, 2005, 23(6), 727-737
4. Biernaskie, J.A., McKenzie, I.A., Toma, J.G., Miller, F.D. Isolation of skin-derived precursors (SKPs) and differentiation and enrichment of their Schwann cell progeny. Nat. Protoc., 2006, 1(6), 2803-2812
5. Ide, C. Peripheral nerve regeneration. Neurosci. Res., 1996, 25(2), 101-121
6. Brushart, T. M. Nerve Repair. Oxford University Press. 2011.
7. Spencer, T.K., Mellado, W., Filbin, M.T. BDNF activates CaMKIV and PKA in parallel to block MAG-mediated inhibition of neurite outgrowth. Mol. Cell Neurosci., 2008, 38(1), 110-116
8. Nakamura, K., Tan, F., Li, Z., Thiele, C.J. NGF activation of TrkA induces vascular endothelial growth factor expression via induction of hypoxiainducible factor-1alpha. Mol. Cell Neurosci., 2011, 46(2), 498-506
9. Blesch, A., Yang, H., Weidner, N., Hoang, A., Otero, D. Axonal responses to cellularly delivered NT-4/5 after spinal cord injury. Mol. Cell Neurosci., 2004, 27(2), 190-201
10. Hu, Y., Leaver, S.G., Plant, G.W., Hendriks, W.T., Niclou, S.P., Verhaagen, J., Harvey, A.R., Cui, Q. Lentiviral-mediated transfer of CNTF to schwann cells within reconstructed peripheral nerve grafts enhances adult retinal ganglion cell survival and axonal regeneration. Mol. Ther., 2005, 11(6), 906-915
11. Nakahara, Y., Gage, F.H., Tuszynski, M.H. Grafts of fibroblasts genetically modified to secrete NGF, BDNF, NT-3, or basic FGF elicit differential responses in the adult spinal cord. Cell Transplant., 1996, 5(2), 191-204
12. Weidner, N., Blesch, A., Grill, R.J., Tuszynski, M.H. Nerve growth factorhypersecreting Schwann cell grafts augment and guide spinal cord axonal growth and remyelinate central nervous system axons in a phenotypically appropriate manner that correlates with expression of L1. J. Comp Neurol., 1999, 413(4), 495-506
13. Li, Q., Ping, P., Jiang, H., Liu, K. Nerve conduit filled with GDNF genemodified Schwann cells enhances regeneration of the peripheral nerve. Microsurgery, 2006, 26(2), 116-121
14. Tannemaat, M.R., Boer, G.J., Eggers, R., Malessy, M.J., Verhaagen, J. From microsurgery to nanosurgery: how viral vectors may help repair the peripheral nerve. Prog. Brain Res., 2009, 175, 173-186
15. Tuszynski, M.H., Murai, K., Blesch, A., Grill, R., Miller, I. Functional characterization of NGF-secreting cell grafts to the acutely injured spinal cord. Cell Transplant., 1997, 6(3), 361-368
16. Eggers, R., Hendriks, W.T., Tannemaat, M.R., van Heerikhuize, J.J., Pool, C.W., Carlstedt, T.P., Zaldumbide, A., Hoeben, R.C., Boer, G.J., Verhaagen, J. Neuroregenerative effects of lentiviral vector-mediated GDNF expression in reimplanted ventral roots. Mol. Cell Neurosci., 2008, 39(1), 105-117
17. Georgievska, B., Kirik, D., Bjorklund, A. Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer. Exp. Neurol., 2002, 177(2), 461-474
18. Rosenblad, C., Georgievska, B., Kirik, D. Long-term striatal overexpression of GDNF selectively downregulates tyrosine hydroxylase in the intact nigrostriatal dopamine system. Eur. J. Neurosci., 2003, 17(2), 260-270
19. Tannemaat, M.R., Eggers, R., Hendriks, W.T., de Ruiter, G.C., van Heerikhuize, J.J., Pool, C.W., Malessy, M.J., Boer, G.J., Verhaagen, J. Differential effects of lentiviral vector-mediated overexpression of nerve growth factor and glial cell line-derived neurotrophic factor on regenerating sensory and motor axons in the transected peripheral nerve. Eur. J. Neurosci., 2008, 28(8), 1467-1479
20. Winkler, C., Georgievska, B., Carlsson, T., Lacar, B., Kirik, D. Continuous exposure to glial cell line-derived neurotrophic factor to mature dopaminergic transplants impairs the graft's ability to improve spontaneous motor behavior in parkinsonian rats. Neuroscience, 2006, 141(1), 521-531
21. Pedroso de Lima, M.C., Neves, S., Filipe, A., Duzgunes, N., Simoes, S. Cationic liposomes for gene delivery: from biophysics to biological applications. Curr. Med. Chem., 2003, 10(14), 1221-1231
22. Thomsen, L.B., Larsen, A.B., Lichota, J., Moos, T. Nanoparticle-derived non-viral genetic transfection at the blood-brain barrier to enable neuronal growth factor delivery by secretion from brain endothelium. Curr. Med. Chem., 2011, 18(22), 3330-3334
23. Arnaiz, E., Doucede, L.I., Garcia-Gallego, S., Urbiola, K., Gomez, R., Tros, d., I, de la Mata, F.J. Synthesis of Cationic Carbosilane Dendrimers via Click Chemistry and Their Use as Effective Carriers for DNA Transfection into Cancerous Cells. Mol. Pharm., 2012
24. Xu, Q., Wang, C.H., Pack, D.W. Polymeric carriers for gene delivery: chitosan and poly(amidoamine) dendrimers. Curr. Pharm. Des, 2010, 16(21), 2350-2368
25. Yuan, Y., Kallos, M.S., Hunter, C., Sen, A. Improved expansion of human bone marrow-derived mesenchymal stem cells in microcarrier-based suspension culture. J. Tissue Eng Regen. Med., 2012
26. Walsh, S., Biernaskie, J., Kemp, S.W., Midha, R. Supplementation of acellular nerve grafts with skin derived precursor cells promotes peripheral nerve regeneration. Neuroscience, 2009, 164(3), 1097-1107
27. Toma, J.G., Akhavan, M., Fernandes, K.J., Barnabe-Heider, F., Sadikot, A., Kaplan, D.R., Miller, F.D. Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat. Cell Biol., 2001, 3(9), 778-784
28. Alfred, R., Radford, J., Fan, J., Boon, K., Krawetz, R., Rancourt, D., Kallos, M.S. Efficient suspension bioreactor expansion of murine embryonic stem cells on microcarriers in serum-free medium. Biotechnol. Prog., 2011, 27(3), 811-823
29. Shakhbazau, A., Isayenka, I., Kartel, N., Goncharova, N., Seviaryn, I., Kosmacheva, S., Potapnev, M., Shcharbin, D., Bryszewska, M. Transfection efficiencies of PAMAM dendrimers correlate inversely with their hydrophobicity. Int. J. Pharm., 2010, 383(1-2), 228-235
30. Shakhbazau, A., Shcharbin, D., Seviaryn, I., Goncharova, N., Kosmacheva, S., Potapnev, M., Gabara, B., Ionov, M., Bryszewska, M. Use of polyamidoamine dendrimers to engineer BDNF-producing human mesenchymal stem cells. Mol. Biol. Rep., 2010, 37(4), 2003-2008
31. Kemp, S.W., Webb, A.A., Dhaliwal, S., Syed, S., Walsh, S.K., Midha, R. Dose and duration of nerve growth factor (NGF) administration determine the extent of behavioral recovery following peripheral nerve injury in the rat. Exp. Neurol., 2011, 229(2), 460-470
32. Himes, B.T., Liu, Y., Solowska, J.M., Snyder, E.Y., Fischer, I., Tessler, A. Transplants of cells genetically modified to express neurotrophin-3 rescue axotomized Clarke's nucleus neurons after spinal cord hemisection in adult rats. J. Neurosci. Res., 2001, 65(6), 549-564
33. Grill, R., Murai, K., Blesch, A., Gage, F.H., Tuszynski, M.H. Cellular delivery of neurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury. J. Neurosci., 1997, 17(14), 5560-5572
34. Pandita, D., Santos, J.L., Rodrigues, J., Pego, A.P., Granja, P.L., Tomas, H. Gene delivery into mesenchymal stem cells: a biomimetic approach using RGD nanoclusters based on poly(amidoamine) dendrimers. Biomacromolecules., 2011, 12(2), 472-481
35. Santos, J.L., Oramas, E., Pego, A.P., Granja, P.L., Tomas, H. Osteogenic differentiation of mesenchymal stem cells using PAMAM dendrimers as gene delivery vectors. J. Control Release, 2009, 134(2), 141-148
36. Santos, J.L., Pandita, D., Rodrigues, J., Pego, A.P., Granja, P.L., Balian, G., Tomas, H. Receptor-mediated gene delivery using PAMAM dendrimers conjugated with peptides recognized by mesenchymal stem cells. Mol. Pharm., 2010, 7(3), 763-774
37. Tao, W., Wen, R., Goddard, M.B., Sherman, S.D., O'Rourke, P.J., Stabila, P.F., Bell, W.J., Dean, B.J., Kauper, K.A., Budz, V.A., Tsiaras, W.G., Acland, G.M., Pearce-Kelling, S., Laties, A.M., Aguirre, G.D. Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa. Invest Ophthalmol. Vis. Sci, 2002, 43(10), 3292-3298
38. Taiani, J.T., Krawetz, R.J., Zur Nieden, N.I., Elizabeth, W.Y., Kallos, M.S., Matyas, J.R., Rancourt, D.E. Reduced differentiation efficiency of murine embryonic stem cells in stirred suspension bioreactors. Stem Cells Dev., 2010, 19(7), 989-998
39. Shafa, M., Krawetz, R., Zhang, Y., Rattner, J.B., Godollei, A., Duff, H.J., Rancourt, D.E. Impact of stirred suspension bioreactor culture on the differentiation of murine embryonic stem cells into cardiomyocytes. BMC. Cell Biol., 2011, 12, 53
40. Brindley, D., Moorthy, K., Lee, J.H., Mason, C., Kim, H.W., Wall, I. Bioprocess forces and their impact on cell behavior: implications for bone regeneration therapy. J. Tissue Eng, 2011, 2011, 620247
41. Shafa, M., Sjonnesen, K., Yamashita, A., Liu, S., Michalak, M., Kallos, M.S., Rancourt, D.E. Expansion and long-term maintenance of induced pluripotent stem cells in stirred suspension bioreactors. J. Tissue Eng Regen. Med., 2012, 6(6), 462-472
42. Kodama, K., Katayama, Y., Shoji, Y., Nakashima, H. The features and shortcomings for gene delivery of current non-viral carriers. Curr. Med. Chem., 2006, 13(18), 2155-2161
43. Jafari, M., Soltani, M., Naahidi, S., Karunaratne, D.N., Chen, P. Nonviral approach for targeted nucleic Acid delivery. Curr. Med. Chem., 2012, 19(2), 197-208
44. Ronsyn, M.W., Daans, J., Spaepen, G., Chatterjee, S., Vermeulen, K., D'Haese, P., Van Tendeloo, V.F., Van Marck, E., Ysebaert, D., Berneman, Z.N., Jorens, P.G., Ponsaerts, P. Plasmid-based genetic modification of human bone marrow-derived stromal cells: analysis of cell survival and transgene expression after transplantation in rat spinal cord. BMC. Biotechnol., 2007, 7, 90-107
45. Kurozumi, K., Nakamura, K., Tamiya, T., Kawano, Y., Kobune, M., Hirai, S., Uchida, H., Sasaki, K., Ito, Y., Kato, K., Honmou, O., Houkin, K., Date, I., Hamada, H. BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. Mol. Ther., 2004, 9(2), 189-197
46. McTigue, D.M., Horner, P.J., Stokes, B.T., Gage, F.H. Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord. J. Neurosci., 1998, 18(14), 5354-5365
47. Jean, I., Lavialle, C., Barthelaix-Pouplard, A., Fressinaud, C. Neurotrophin-3 specifically increases mature oligodendrocyte population and enhances remyelination after chemical demyelination of adult rat CNS. Brain Res., 2003, 972(1-2), 110-118
48. Shang, A.J., Hong, S.Q., Xu, Q., Wang, H.Y., Yang, Y., Wang, Z.F., Xu, B.N., Jiang, X.D., Xu, R.X. NT-3-secreting human umbilical cord mesenchymal stromal cell transplantation for the treatment of acute spinal cord injury in rats. Brain Res., 2011, 1391, 102-113
49. Gu, Y.L., Yin, L.W., Zhang, Z., Liu, J., Liu, S.J., Zhang, L.F., Wang, T.H. Neurotrophin Expressions in Neural Stem Cells Grafted Acutely to Transected Spinal Cord of Adult Rats Linked to Functional Improvement. Cell Mol. Neurobiol., 2012
50. Zhang, W., Yan, Q., Zeng, Y.S., Zhang, X.B., Xiong, Y., Wang, J.M., Chen, S.J., Li, Y., Bruce, I.C., Wu, W. Implantation of adult bone marrow-derived mesenchymal stem cells transfected with the neurotrophin-3 gene and pretreated with retinoic acid in completely transected spinal cord. Brain Res., 2010, 1359, 256-271
51. Carmen, I.H. A death in the laboratory: the politics of the Gelsinger aftermath. Mol. Ther., 2001, 3(4), 425-428
52. Somia, N. and Verma, I.M. Gene therapy: trials and tribulations. Nat. Rev. Genet., 2000, 1(2), 91-99
53. Longo, S.L., Griffith, C., Glass, A., Shillitoe, E.J., Post, D.E. Development of an oncolytic herpes simplex virus using a tumor-specific HIF-responsive promoter. Cancer Gene Ther., 2011, 18(2), 123-134
54. http://clinicaltrials.gov/ct2/show/NCT01621581
55. Tuszynski, M.H., Thal, L., Pay, M., Salmon, D.P., HS, U., Bakay, R., Patel, P., Blesch, A., Vahlsing, H.L., Ho, G., Tong, G., Potkin, S.G., Fallon, J., Hansen, L., Mufson, E.J., Kordower, J.H., Gall, C., Conner, J. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat. Med., 2005, 11(5), 551-555
56. http://clinicaltrials.gov/ct2/show/NCT01163825
57. Sieving, P.A., Caruso, R.C., Tao, W., Coleman, H.R., Thompson, D.J., Fullmer, K.R., Bush, R.A. Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants. Proc. Natl. Acad. Sci U. S. A, 2006, 103(10), 3896-3901
58. http://clinicaltrials.gov/ct2/show/NCT00063765
59. Aebischer, P., Schluep, M., Deglon, N., Joseph, J.M., Hirt, L., Heyd, B., Goddard, M., Hammang, J.P., Zurn, A.D., Kato, A.C., Regli, F., Baetge, E.E. Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients. Nat. Med., 1996, 2(6), 696-699
60. http://clinicaltrials.gov/ct2/show/NCT01411657
61. http://clinicaltrials.gov/ct2/show/NCT01408472
62. Sahota, P. and Savitz, S.I. Investigational therapies for ischemic stroke: neuroprotection and neurorecovery. Neurotherapeutics., 2011, 8(3), 434-451
63. McColgan, P., Sharma, P., Bentley, P. Stem cell tracking in human trials: a meta-regression. Stem Cell Rev., 2011, 7(4), 1031-1040
64. Ferrero, I., Mazzini, L., Rustichelli, D., Gunetti, M., Mareschi, K., Testa, L., Nasuelli, N., Oggioni, G.D., Fagioli, F. Bone marrow mesenchymal stem cells from healthy donors and sporadic amyotrophic lateral sclerosis patients. Cell Transplant., 2008, 17(3), 255-266
65. Mazzini, L., Ferrero, I., Luparello, V., Rustichelli, D., Gunetti, M., Mareschi, K., Testa, L., Stecco, A., Tarletti, R., Miglioretti, M., Fava, E., Nasuelli, N., Cisari, C., Massara, M., Vercelli, R., Oggioni, G.D., Carriero, A., Cantello, R., Monaco, F., Fagioli, F. Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial. Exp. Neurol., 2010, 223(1), 229-237
66. Zhou, H., Chang, S., Rao, M. Human cord blood applications in cell therapy: looking back and look ahead. Expert. Opin. Biol. Ther., 2012
67. Baghbaderani, B.A., Mukhida, K., Sen, A., Kallos, M.S., Hong, M., Mendez, I., Behie, L.A. Bioreactor expansion of human neural precursor cells in serum-free media retains neurogenic potential. Biotechnol. Bioeng., 2010, 105(4), 823-833
68. Kallos, M.S. and Behie, L.A. Inoculation and growth conditions for highcell-density expansion of mammalian neural stem cells in suspension bioreactors. Biotechnol. Bioeng., 1999, 63(4), 473-483
69. Niebruegge, S., Nehring, A., Bar, H., Schroeder, M., Zweigerdt, R., Lehmann, J. Cardiomyocyte production in mass suspension culture: embryonic stem cells as a source for great amounts of functional cardiomyocytes. Tissue Eng Part A, 2008, 14(10), 1591-1601
70. Zur Nieden, N.I., Cormier, J.T., Rancourt, D.E., Kallos, M.S. Embryonic stem cells remain highly pluripotent following long term expansion as aggregates in suspension bioreactors. J. Biotechnol., 2007, 129(3), 421-432
71. Alfred, R., Taiani, J.T., Krawetz, R.J., Yamashita, A., Rancourt, D.E., Kallos, M.S. Large-scale production of murine embryonic stem cell-derived osteoblasts and chondrocytes on microcarriers in serum-free media. Biomaterials, 2011, 32(26), 6006-6016
72. Keilhoff, G., Stang, F., Goihl, A., Wolf, G., Fansa, H. Transdifferentiated mesenchymal stem cells as alternative therapy in supporting nerve regeneration and myelination. Cell Mol. Neurobiol., 2006, 26(7-8), 1235-1252
73. Biernaskie, J., Sparling, J.S., Liu, J., Shannon, C.P., Plemel, J.R., Xie, Y., Miller, F.D., Tetzlaff, W. Skin-derived precursors generate myelinating Schwann cells that promote remyelination and functional recovery after contusion spinal cord injury. J. Neurosci., 2007, 27(36), 9545-9559
74. Simpson, P.J., Wang, E., Moon, C., Matarazzo, V., Cohen, D.R., Liebl, D.J., Ronnett, G.V. Neurotrophin-3 signaling maintains maturational homeostasis between neuronal populations in the olfactory epithelium. Mol. Cell Neurosci., 2003, 24(4), 858-874.